34
hits | 2929 7th St Ste 130, Berkeley, CA 94710
1 510 549 5500
|
Overview:
Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing biotherapeutics. The company maintains a solid intellectual property position with its strong portfolio of potential breakthrough products now in clinical development and several pre-clinical programs. The lead products are human recombinant proteins: AEROVANT , an IL-4 and IL-13 receptor antagonist currently in Phase 2a studies for asthma; AEROLYTIC , a serine protease inhibitor in Phase 2a for Cystic Fibrosis; AERODERM , an IL-4 and IL-13 receptor antagonist in Phase 2a for eczema, and PULMOLYTIC , a serine protease inhibitor in Phase 2a for COPD. Aerovance was spun off from Bayer Healthcare's biotechnology unit in August 2004 and has a proven executive team, experienced in the field of respiratory disease and biologics drug development. The company's venture capital investors are Alta Partners, APAX Partners, Burrill & Company, Clarus Ventures, Lehman Brothers and NGN... | |
|
Other Suggestions in this industry: |
|
Other Suggestions in city: Berkeley |
|
|
